Medication price comparisons remain opaque because multiple price definitions exist and patients typically learn ...
Moving the 340B program from upfront discounts to a rebate model would add work for health systems but likely wouldn't change the picture for employers and other plan sponsors, ac ...
A pharmacist-led specialty pharmacy model that expands into care management services could help health systems improve chronic disease outcomes while supporting cost savings under value-based care, ...
Teledentistry has become an important tool for helping patients access dental expertise when and where they need it. It can ...
Birth volume was the dominant predictor; lowest-volume rural hospitals had 36% predicted obstetric unit closure probability versus 5% in highest-volume rural hospitals, and low-volume urban hospitals ...
Steering claims away from 340B-eligible pharmacies is one option but also the most disruptive, said Jeff Dunn, Pharm.D., MBA, of NeosRx. Employers and other plan sponsors have few good options for ...
This is connected care in action: bringing together data, benefits, and personalized support to improve health outcomes while helping manage long-term healthcare costs. The value comes not from ...
Just two therapies are available to treat MASH. The first was Madrigal Pharmaceuticals’ Rezdiffra (resmetirom), which was ...
Chad Hatfield, Pharm.D., M.H.A., BCPS, vice president and chief pharmacy officer of UC Davis Health, says pharmacists are embedded in “nearly all specialties," with more than 150 holding board ...
In stage II–IIIA disease, adjuvant osimertinib reduced mortality risk by 47%, with 74% alive at eight years versus 58% with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results